van Lent, Liza G. G. http://orcid.org/0000-0002-4979-3051
Stoel, Nicole K.
van Weert, Julia C. M.
van Gurp, Jelle
de Jonge, Maja J. A.
Lolkema, Martijn P.
Gort, Eelke H.
Pulleman, Saskia M.
Oomen-de Hoop, Esther
Hasselaar, Jeroen
van der Rijt, Carin C. D.
Funding for this research was provided by:
KWF Kankerbestrijding (KWF11086)
Article History
Received: 11 October 2019
Accepted: 1 November 2019
First Online: 29 November 2019
Ethics approval and consent to participate
: The Medical Ethics Committee Erasmus MC of Rotterdam, The Netherlands, has reviewed the research proposal for the above mentioned multicentre project and assessed that the rules laid down in the Medical Research Involving Human Subjects Act, do not apply (MEC-2018-151). Research governance approval was received from all participating hospitals. All participants are informed of the aims of the component of the study for which they are invited to voluntarily participate (i.e., interviews, focus groups, think aloud sessions, pre-test and post-test). Written consent will be collected beforehand in all study components, with the exception of participants in the pre-test and post-test due to the limited available time before the patients’ first consultation with a study oncologist after planning the consultation. Therefore, preliminary oral consent and additional consent questions will be asked before the start of the first questionnaire (T1), and written consent is collected afterwards, directly before the start of the upcoming consultation (T2). Furthermore, all medical oncologists and fellow medical oncologists whose consultations will be recorded, will be informed about the study and asked for written informed consent before their first consultation is recorded.
: Not applicable.
: The authors declare that they have no competing interests.